Sandoz

ZARXIO - Cost

Last Updated: April 1st, 2024

HCPCS:

Q5101

HCPCS Code Descriptor:

Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram

Medicare Payment Limit:

The ZARXIO Medicare Payment Limit is $0.423

Average Sale Price:

ZARXIO ASP cost available once logged in. Zarxio is a biosimilar drug making the ASP calculation more complex. Zarxio's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The ZARXIO Medicare Co-insurance percentage is 20%. ZARXIO's Medicare Co-insurance amount is $0.08 per HCPCS unit.

APC Code:

The Zarxio APC Code is: 1822

APC Payment Limit:

The APC Payment Limit for ZARXIO is available. Login to view.

Zarxio Cost Information:

Zarxio (Q5101), active ingredient filgrastim, is a biosimilar to the reference product Neupogen (J1442). Zarxio’s WAC and AWP prices have remained steady while it’s ASP has fallen significantly over the past decade to less than 20% of its original value. This is likely due to high competition among the filgrastim biosimilar medications.

ACCESS PRICING AND MORE BY REGISTERING

Zarxio’s wholesale acquisition cost (WAC) information was last updated on:
April 1, 2019
Zarxio’s average wholesale price (AWP) information was last updated on:
April 1, 2019